| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.6M | +19.7% |
| R&D Expense | $13.6M | -6.8% |
| SG&A Expense | $22.8M | +3.7% |
| Operating Income | -$47.4M | +5.1% |
| Pre-tax Income | -$47.1M | -0.5% |
| Income Tax | $40K | +81.8% |
| Net Income | -$47.1M | -0.5% |
| EPS (Basic) | -$1.05 | +2.8% |
| EPS (Diluted) | -$1.05 | +2.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | +18.4% |
| Accounts Receivable | $3.1M | -58.3% |
| Inventory | $17.6M | -12.9% |
| Current Assets | $61.2M | -24.4% |
| Total Assets | $74.9M | -23.8% |
| Current Liabilities | $18.5M | +5.2% |
| Long-term Debt | $18.9M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.1M | +29.6% |
| Capital Expenditures | $850K | -37.7% |
| Investing Cash Flow | $14.3M | -60.9% |
| Financing Cash Flow | $19.8M | +9639.4% |
| Free Cash Flow | -$31.9M | +29.9% |
| $41.6M |
| +82.5% |
| Stockholders' Equity | $33.2M | -55.9% |